Tourette Discrimination (TD) Stigma Scale
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jan 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Tourette Discrimination (TD) Stigma Scale, is exploring the challenges faced by children and young adults with Chronic Tic Disorders (CTD), which includes Tourette Syndrome. The main goal is to understand how stigma and discrimination affect their lives. By gathering this information, the researchers hope to find better ways to support individuals with CTD in the future.
The study is currently looking for participants aged 8 to 30 who have been diagnosed with CTD by a doctor. If you are a parent, caregiver, or supporter of someone with CTD and you've been involved in their care, you can also take part. However, participants need to speak English and should not have certain conditions, like intellectual disabilities or psychosis, that might make it hard for them to understand the study. If you join the study, you can expect to share your experiences and insights, which will be valuable for understanding and addressing the stigma surrounding tic disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • CTD Cohort
- • 1. Physician-confirmed diagnosis of CTD based on the Diagnostic and Statistical Manual for Mental Disorders-Fifth Edition (DSM-V) criteria
- • 2. 8-30 years old.
- • Parent/caregivers, supporters, medical providers, advocate cohort (s)
- • 1. Involved in the care of a child, youth or young adult with CTD
- • 2. The known person with CTD has had tics for more than a year at the time of screening
- Exclusion Criteria:
- • CTD Cohort
- Exclusion criteria:
- • 1. Non-English speaking
- • 2. Diagnosis of intellectual disability
- • 3. Diagnosis of psychosis
- • 4. Any other condition that, in the Principle Investigator's opinion, would limit the participant's (or parent's) ability to understand study measures.
- • Parent/caregivers, supporters, medical providers, advocate cohort (s)
- • 1) The known person with CTD has an intellectual disability or diagnosis of psychosis
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Jaclyn M Martindale, DO
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials